Gynecologic Oncology

Bone and Calcium Disorders

Questions discussed in this category

Would you transition from denosumab to anabolic agents in patients who are in urgent need for extensive dental work?

2 Answers available

Papers discussed in this category

The lancet. Diabetes & endocrinology, 2019 Aug 22

Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial.

Related Topics in Gynecologic Oncology